HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frédéric Colland Selected Research

S55746

1/2019Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia.
4/2018S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frédéric Colland Research Topics

Disease

11Neoplasms (Cancer)
11/2020 - 11/2007
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2018 - 11/2007
4Multiple Myeloma
10/2016 - 11/2007
3Leukemia
11/2020 - 10/2016
3Neurodegenerative Diseases (Neurodegenerative Disease)
02/2010 - 11/2007
3Virus Diseases (Viral Diseases)
02/2010 - 02/2008
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2018
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2018
1Lymphoma (Lymphomas)
10/2016
1Peritonitis
10/2010
1Infections
10/2010
1Pathologic Processes
02/2010

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
11/2020 - 02/2010
3Bortezomib (Velcade)FDA Link
02/2010 - 11/2007
3Proteasome InhibitorsIBA
02/2010 - 11/2007
3UbiquitinIBA
08/2009 - 11/2007
3Proteasome Endopeptidase Complex (Proteasome)IBA
08/2009 - 11/2007
2S55746IBA
01/2019 - 04/2018
2S63845IBA
01/2019 - 10/2016
1Apoptosis Regulatory ProteinsIBA
04/2018
1venetoclaxIBA
04/2018
1Homeodomain Proteins (Proteins, Homeobox)IBA
08/2013
1Cytostatic AgentsIBA
08/2013
1Deubiquitinating EnzymesIBA
04/2012
1Ubiquitin-Specific ProteasesIBA
05/2011
1DNA (Deoxyribonucleic Acid)IBA
05/2011
1Pharmaceutical PreparationsIBA
05/2011
1EnzymesIBA
05/2011
1CytokinesIBA
10/2010
1ChemokinesIBA
10/2010
1Peptide Hydrolases (Proteases)FDA Link
02/2010
1Protease Inhibitors (Protease Inhibitor)IBA
02/2010
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
08/2009
1HBX 41,108IBA
08/2009
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
08/2009
1Viral ProteinsIBA
08/2009
1Phosphotransferases (Kinase)IBA
04/2009

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2020 - 01/2019
2Therapeutics
11/2020 - 04/2012